newsfilter
← Latest News
ACCESS Newswire·

Jaguar Health Reports Positive Consumer and Veterinary Market Research Findings Supporting Commercial Opportunity for Neonorm Dog

  • Jaguar Health announced Neonorm Dog, an extension of its Neonorm franchise designed to support normal stool consistency & GI fluid balance in dogs.
  • The product is a plant-based, non-prescription supplement containing standardized botanical extract from the sustainably harvested Croton lechleri tree.
  • Exploratory surveys of 33 veterinary oncologists showed 90% viewed the concept as clinically relevant & nearly 80% indicated they would recommend it for canine oncology patients.
  • A survey of 18 dog owners revealed 83% found the concept appealing & 94% indicated they would likely purchase the product.
  • Jaguar expects to launch Neonorm Dog through select online & animal health retail channels, specifically including Amazon & Chewy.
  • The company is currently finalizing packaging, labeling, & commercial launch preparations for the product.
  • Existing Neonorm products include Neonorm Foal & Neonorm Calf, which support hydration & bowel health in pre-weaned foals & calves.
  • Neonorm Dog is not intended to diagnose, treat, cure, or prevent any disease, nor is it a substitute for veterinary care.